Michael J. Goldstein, M.D.
- American Board of Surgery
- Transplant Surgery
- Associate Professor of Surgery (Pending Rank)
- Executive Director - LAORA
With leadership positions in both organ donation and transplantation, Dr. Goldstein focuses on improving the clinical management of organ donors with the goal of maximizing the utilization of deceased donor organs for transplantation. He has directed his clinical efforts to increase patient access to transplantation and the successful transplantation of high-risk recipients. Previously, his efforts assisted the Weill-Cornell Medical College in growing deceased donor organ utilization by over 400%. He joined the Columbia University faculty as the Surgical Director of Pediatric Abdominal Transplantation to lead the growth of abdominal organ transplantation in children at the Morgan Stanley Children’s Hospital of New York. He later served as the Director of Renal and Pancreatic Transplantation Recanati/Miller Transplantation Institute at Mount Sinai Medical Center in New York prior to his arrival in Miami, FL. He has been invited to lecture on transplant growth and aggressive clinical style at numerous institutions. He has been an active consultant for the New York Organ Donor Network with positions on the Medical Advisory Board, Performance Improvement Committee, and the Kidney-Pancreas Subcommittee. In June 2009, Dr. Goldstein became the Medical Director of the New York Organ Donor Network to further champion efforts for improving organ donation and served in that role for 4 years. Outside of his Regional duties in New York, he served as the Vice-Chair of the UNOS Organ Availability Committee and the Medical Directors Council of the Association of Organ Procurement Organizations.
In addition to his active roles as an administrator and clinician, Dr. Goldstein is an author of many manuscripts and editorials focusing on clinical transplantation outcomes, organ donor management, organ ischemia/preservation, and the changing nature and modernization of surgical education. He led a team of researchers to improve the management of the deceased organ donor and enhance organ quality at the New York Organ Donor Network and with particular expertise in the topic of renal machine perfusion. Furthermore, he is one of the founding members of a National strategy for donor research.
Dr. Goldstein has been an active participant in the HRSA Organ Transplantation Breakthrough Collaborative (OTBC) since its inception. He has been an invited speaker for the OTBC on Donor Service Area (DSA) challenges and successes, optimizing organ acceptance, transplanting organs with glomerulosclerosis, and regional disparities in access to organ transplantation. He has been a member of the Collaborative faculty for the Transplantation Growth and Management Collaborative and was co-Chair of the National Learning Congress for Organ Donation and Transplantation Community of Practice. He serves on the HRSA-sponsored Donor Management Task Force, as well as, the Transplant Center Task Force to develop new quality metrics for transplant centers.
Dr. Goldstein is a Fellow of the American College of Surgeons, member of the American Society for Transplant Surgeons, American Society for Transplantation, and the Association of Academic Surgeons. He served as a medical advisor to the National Kidney Foundation of Greater New York, as well as, numerous pharmaceutical and biotechnical companies for improving transplantation outcomes and patient care. Dr. Goldstein received his Bachelor of Arts in Neurobiology at the University of Pennsylvania and his Medical Doctorate at the Temple University School of Medicine. He completed both his post-doctoral residency fellowship in General Surgery and his abdominal transplantation fellowship at New York Presbyterian Hospital-Columbia University Medical Center.